🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Background: Advanced urothelial cancer has no cure. But only a few chemoth...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2017-03-27
Trial ID
NCT02788201
Treatments Being Tested
This study is a randomized controlled, open-label, multicenter phase III cl...
Status
Recruiting
Location
Erwei Song
Start Date
2023-12-01
Trial ID
NCT06079983
This is a feasibility study in patients with localized or metastatic soft t...
Status
Completed
Location
Monter Cancer Center (Northwell Health)
Start Date
2016-12-15
Trial ID
NCT03056599
Treatments Being Tested
The goal of this research study is to evaluate the safety and feasibility o...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-05
Trial ID
NCT05774886
Treatments Being Tested
The eribulin, a microtubule-dynamics inhibitor was approved for specific su...
Status
Completed
Location
Severance Hospital, Yonsei University Health System
Start Date
2018-03-27
Trial ID
NCT03810976
Treatments Being Tested
The purpose of this study is to determine whether Patients with Locally Adv...
Status
Terminated
Location
Multiple Locations
Start Date
2010-04-16
Trial ID
NCT01126749
Treatments Being Tested
This is a therapeutic exploratory Phase 2 study evaluating AEZS-108 compare...
Status
Terminated
Location
University of Miami
Start Date
2012-12
Trial ID
NCT01698281
Treatments Being Tested
The primary objective of this study is to explore the efficacy and safety o...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2025-09-15
Trial ID
NCT07088263
Treatments Being Tested
The primary objective of this study is to assess and compare the efficacy a...
Status
Completed
Location
HonorHealth Research Institute
Start Date
2019-05-08
Trial ID
NCT03901339
Treatments Being Tested
This study is a Phase II, multi-site, randomized, open-label clinical study...
Status
Active Not Recruiting
Location
Beverly Hills Cancer Center
Start Date
2024-08-26
Trial ID
NCT06449222